These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30181129)

  • 1. Urea for the Treatment of Hyponatremia.
    Rondon-Berrios H; Tandukar S; Mor MK; Ray EC; Bender FH; Kleyman TR; Weisbord SD
    Clin J Am Soc Nephrol; 2018 Nov; 13(11):1627-1632. PubMed ID: 30181129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Safety and Effectiveness of Urea and Tolvaptan for the Management of Hyponatremia.
    Scalla PA; Palma SM; Dittmar E; Zamora FJ; Trimino E
    J Pharm Pract; 2024 Dec; 37(6):1252-1257. PubMed ID: 38652561
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of euvolemic hyponatremia in the intensive care unit by urea.
    Decaux G; Andres C; Gankam Kengne F; Soupart A
    Crit Care; 2010; 14(5):R184. PubMed ID: 20946646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
    Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
    Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH.
    Soupart A; Coffernils M; Couturier B; Gankam-Kengne F; Decaux G
    Clin J Am Soc Nephrol; 2012 May; 7(5):742-7. PubMed ID: 22403276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia.
    George JC; Zafar W; Bucaloiu ID; Chang AR
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):984-992. PubMed ID: 29871886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Effects of Enteral Urea on Intracranial Pressure in Patients With Acute Brain Injury and Hyponatremia.
    Annoni F; Fontana V; Brimioulle S; Creteur J; Vincent JL; Taccone FS
    J Neurosurg Anesthesiol; 2017 Oct; 29(4):400-405. PubMed ID: 27438797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
    Verbalis JG; Greenberg A; Burst V; Haymann JP; Johannsson G; Peri A; Poch E; Chiodo JA; Dave J
    Am J Med; 2016 May; 129(5):537.e9-537.e23. PubMed ID: 26584969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urea treatment in fluid restriction-refractory hyponatraemia.
    Lockett J; Berkman KE; Dimeski G; Russell AW; Inder WJ
    Clin Endocrinol (Oxf); 2019 Apr; 90(4):630-636. PubMed ID: 30614552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
    Zeltser D; Rosansky S; van Rensburg H; Verbalis JG; Smith N;
    Am J Nephrol; 2007; 27(5):447-57. PubMed ID: 17664863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Tolerability of Conivaptan and Tolvaptan for the Treatment of Hyponatremia in Neurocritically Ill Patients.
    Der-Nigoghossian C; Lesch C; Berger K
    Pharmacotherapy; 2017 May; 37(5):528-534. PubMed ID: 28295447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.
    Murphy T; Dhar R; Diringer M
    Neurocrit Care; 2009; 11(1):14-9. PubMed ID: 19123060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients.
    Coussement J; Danguy C; Zouaoui-Boudjeltia K; Defrance P; Bankir L; Biston P; Piagnerelli M
    Am J Nephrol; 2012; 35(3):265-70. PubMed ID: 22378162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study.
    Burst V; Grundmann F; Kubacki T; Greenberg A; Becker I; Rudolf D; Verbalis J
    Am J Nephrol; 2017; 45(5):420-430. PubMed ID: 28419981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conivaptan for hyponatremia in the neurocritical care unit.
    Wright WL; Asbury WH; Gilmore JL; Samuels OB
    Neurocrit Care; 2009; 11(1):6-13. PubMed ID: 19003543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urea in cancer patients with chronic SIAD-induced hyponatremia: Old drug, new evidence.
    Nervo A; D'Angelo V; Rosso D; Castellana E; Cattel F; Arvat E; Grossi E
    Clin Endocrinol (Oxf); 2019 Jun; 90(6):842-848. PubMed ID: 30868608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
    Sood L; Sterns RH; Hix JK; Silver SM; Chen L
    Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations.
    Jahangiri A; Wagner J; Tran MT; Miller LM; Tom MW; Kunwar S; Blevins L; Aghi MK
    J Neurosurg; 2013 Dec; 119(6):1478-83. PubMed ID: 23971964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients.
    Reeder RF; Harbaugh RE
    J Neurosurg; 1989 Feb; 70(2):201-6. PubMed ID: 2913218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy.
    Decaux G; Unger J; Brimioulle S; Mockel J
    JAMA; 1982 Jan 22-29; 247(4):471-4. PubMed ID: 7054549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.